SciSight Ecosystem
WoS ESCI Q2Scopus Q2SCImago #4,219CAS 3区Top JournalReview JournalGold OA

Oncology Reviews

Country: Italy•WoS SCIE Quartile: Q2•Scopus SJR: 1.096•SCImago Rank: #4,219•Identifier (ISSN):1970-5557(Print)/1970-5565(Online)•Articles / Year: 14•Estimated Publication Fee (APC): $3,253 USD
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)Q2
4
↓ -1.2

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (Hirsch Index)
35

35 papers with at least that number of citations each

WoS: ESCITop Tier
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
14articles/year
100% Gold OA•0% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.75pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q2 có IF ≥ 2.0(IF: 4)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.75đ
WoS Q2 có IF ≥ 2.0(IF: 4)
🔵 Computed
20251.75đ
WoS Q2 có IF ≥ 2.0(IF: 5.2)
🔵 Computed
20241.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.1)
🔵 Computed
20231.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.6)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Oncology Reviews is a quarterly peer-reviewed, international journal that publishes authoritative state-of-the-art reviews on preclinical and clinical aspects of oncology. The journal will provide up-to-date information on the latest achievements in different fields of oncology for both practising clinicians and basic researchers. Oncology Reviews aims at being international in scope and readership, as reflected also by its Editorial Board, gathering the world leading experts in both pre-clinical research and everyday clinical practice. The journal is open for publication of supplements, monothematic issues and for publishing abstracts of scientific meetings; conditions can be obtained from the Editor-in-Chief or the publisher.

Topics Covered (Recognized by AI)
MedicineBiology96.9%Internal medicine95.8%Genetics91.5%Cancer72.3%Pathology58.5%Oncology51.1%Surgery45.5%Chemistry45.4%Biochemistry38.6%Immunology32.3%Cancer research29.7%Radiology29%Chemotherapy23.3%Psychology21.9%Endocrinology20.1%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,219Scopus Q2SCImago Profile
Scopus Coverage:2007-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
1.096

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
35

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
3.86

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,253 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations290
3-Year Documents58
Citable Documents58

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate41.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ2
OncologyQ2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
PAGEPress Publications
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRESCI
116/333Q2
ONCOLOGY
JCIESCI
206/333Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—5926
20255.250332
20243.134295
20233.612182
2022—9314
2021—17183
2020—20651
2019—24741
2018—19607
2017—121,216
2016—13392
2015—7268
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Oncology Reviews

WoS Q2
23562023202420255.20
Annual Impact Factor Metric
2025:5.2

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: b75e7f69-be8e-4d37-a169-2b216a8bb3cd
Database Updated: 2026-10-01